CDD Vault Integration Bolsters D5 Therapeutics’ Synthetic Lethality Seoul, Korea and San Francisco, CA – March 14, 2023 – D5 Therapeutics, a biotechnology company focused on discovering novel targets and developing innovative medicines using a synthetic lethality (SL) approach, has announced t...
CDD Vault Integration Bolsters D5 Therapeutics’ Synthetic Lethality CDD Vault Integration Bolsters D5 Therapeutics’ Synthetic Lethality CDD Vault Integration Bolsters D5 Therapeutics' Synthetic Lethality Seoul, Korea and San Francisco, CA — March 14, 2023 — D5 Therapeutics, a biotechnology company focused on discovering novel targets and developing innovative medicines using a synthetic lethality (SL) approach, has announced today that it has adopted CDD… by Brian Moore, CDD Webpage: https://ift.tt/SGWgw4i Bengaluru: March 14, 2023 at 10:23AM |
Zastra's JournalArchives
April 2023
Categories |